Valuation: Lifecare ASA

Market Cap 95.4M 10.11M 8.73M 8.2M 7.46M 14.02M 966M 14.26M 96.1M 37.58M 484M 37.94M 37.12M 1.61B P/E 2026 *
-0.84x
P/E 2027 * -1.14x
Enterprise Value 131M 13.92M 12.02M 11.3M 10.27M 19.32M 1.33B 19.63M 132M 51.76M 667M 52.26M 51.13M 2.21B EV / Sales 2026 *
-
EV / Sales 2027 * 26.7x
Free-Float
89.66%
Yield 2026 *
-
Yield 2027 * -
1 day-0.63%
1 week-0.62%
Current month-4.22%
1 month+13.57%
3 months-15.43%
6 months-24.82%
Current year-90.25%
1 week 0.31
Extreme 0.307
0.33
1 month 0.28
Extreme 0.276
0.38
Current year 0.27
Extreme 0.27
1.99
1 year 0.27
Extreme 0.27
17.7
3 years 0.27
Extreme 0.27
82.16
5 years 0.27
Extreme 0.27
82.16
10 years 0.27
Extreme 0.27
117
Manager TitleAgeSince
Chief Executive Officer 50 07/09/2020
Director of Finance/CFO - 01/04/2026
Corporate Officer/Principal - 01/03/2024
Director TitleAgeSince
Director/Board Member - 26/06/2020
Chairman - 08/05/2021
Director/Board Member - 20/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-0.62%-98.20%-98.76% 10.04M
-1.78%-1.68%+1.99%+13.84% 49.24B
+0.85%-0.90%+464.44%+577.70% 43.3B
-2.39%-0.43%+11.98%+69.88% 40.48B
-2.07%-0.68%+25.17%+7.70% 39.75B
-0.50%+3.08%+19.91%+47.26% 32.67B
+0.71%-3.73% - - 16.23B
-0.60%-2.26%+25.87%+117.35% 16.24B
+0.49%+0.80%+5.45%+22.29% 14.04B
-0.54%+3.90%+78.39%+28.14% 13.43B
Average -0.74%+2.06%+59.44%+87.27% 26.54B
Weighted average by Cap. -1.02%+2.54%+95.89%+132.32%

Financials

2026 *2027 *
Net sales - 5M 530K 457K 430K 391K 735K 50.65M 747K 5.04M 1.97M 25.36M 1.99M 1.95M 84.28M
Net income -86M -9.11M -7.87M -7.39M -6.72M -12.64M -871M -12.85M -86.64M -33.87M -436M -34.2M -33.46M -1.45B -82M -8.69M -7.5M -7.05M -6.41M -12.05M -831M -12.25M -82.61M -32.3M -416M -32.61M -31.91M -1.38B
Net Debt 36M 3.81M 3.29M 3.1M 2.81M 5.29M 365M 5.38M 36.27M 14.18M 183M 14.32M 14.01M 607M 38M 4.03M 3.48M 3.27M 2.97M 5.59M 385M 5.68M 38.28M 14.97M 193M 15.11M 14.79M 641M
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
25
Date Price Change Volume
14/08/26 NOK 0.3180 -0.62% 876,442
13/08/26 NOK 0.3200 +0.31% 1,663,237
12/08/26 NOK 0.3190 -1.09% 1,801,074
11/08/26 NOK 0.3225 +3.04% 2,328,474
10/08/26 NOK 0.3130 -2.19% 1,204,847

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIFE Stock